The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

@article{Jaggar1998TheAA,
  title={The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain},
  author={Sian Isobel Jaggar and Fauzia Hasnie and Senthy V. Sellaturay and Andrew S. C. Rice},
  journal={Pain},
  year={1998},
  volume={76},
  pages={189-199},
  url={https://api.semanticscholar.org/CorpusID:6250848}
}
View on Elsevier
druglibrary.org
361 Citations
Highly Influential Citations
11
Background Citations
103
Methods Citations
5
Results Citations
3

Figures from this paper

361 Citations

The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder

Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB1 and CB2-like receptors

Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat

Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain.

Cannabinoids are highly potent and efficacious antihyperalgesic agents in a model of neuropathic pain and are likely to be mediated via an action in the CNS and in the periphery.

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and neurotrophic factors

Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat

The antiinflammatory effect of nabilone is shown and that of palmitoylethanolamide is confirmed indicating that these actions are mediated by an uncharacterized CB2‐like cannabinoid receptor.

The capsaicin analogue SDZ249-665 attenuates the hyper-reflexia and referred hyperalgesia associated with inflammation of the rat urinary bladder

A Novel Neuroimmune Mechanism in Cannabinoid-mediated Attenuation of Nerve Growth Factor–induced Hyperalgesia

Cannabinoids show a neuronal CB1 receptor–mediated antihyperalgesic action and a separate inhibition of a proinflammatory neuroimmune process, which suggests a therapeutic site of analgesic action separable from central side effects.
...

75 References

The modulatory effects of Bradykinin B1 and B2 receptor antagonists upon viscero-visceral hyper-reflexia in a rat model of visceral hyperalgesia

Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat

It is demonstrated that AEA in the unanaesthetized rat exerts behavioural and physiological effects generally similar to those seen following natural cannabinoids and synthetic cannabimimetic agents and suggests a role for AEE in regulation of various physiological processes.

The analgesic effects of R(+)-WIN 55,212–2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.

The dose‐related effects of paracetamol on hyperalgesia and nociception in the rat

The results suggest that paracetamol can reduce hyperalgesia without affecting physiological nociception and inflammation.

Spinal and supraspinal components of cannabinoid-induced antinociception.

Pre-emptive intrathecal administration of an NMDA receptor antagonist (AP-5) prevents hyper-reflexia in a model of persistent visceral pain

Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.

...